BGI LifeTech to Sell DNAStar's Software in China, Hong Kong | GenomeWeb

NEW YORK (GenomeWeb News) — The Beijing Genomics Institute’s BGI LifeTech segment will sell DNAStar’s bioinformatics software in China and Hong Kong, DNAStar said today.

Under the agreement, BGI LifeTech has acquired the rights to sell the Lasergene, ArrayStar, Seqman Genome Assembler, and GenVision products.
 
The company’s software platforms are used in analyzing sequence data, microarray gene expression data, and genomic visualizations.

Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.